print


Breadcrumb Navigation


Content
Prof. Dr. Stefan Zahler

Prof. Dr. Stefan Zahler

Adjunct Professor
Group Leader
Head of Imaging Facility

Contact

University of Munich
Department of Pharmacy - Center for Drug Research
Pharmaceutical Biology
Butenandtstr. 5-13
81377 Munich
Germany

Office: B 4.002

Phone: +49-89-2180-77196
Fax: +49-89-2180-77170

Office hours:
Monday and Thursday 1.00-2.00 pm

Project description

Angiogenesis, the formation of new blood vessels is important for physiological (e.g. wound healing) and pathological (e.g. tumor growth) processes.

We are interested in inhibiting angiogenesis mainly in the tumor context as very promising therapeutic option. The molecular target structures we currently investigate are the kinase CDK5 and the cytoskeleton proteins tubulin and actin.

By using and characterizing novel inhibitors of natural origin (e.g. isolated from myxobacteria) we gain insight into basic cell biological questions, and try to establish innovative classes of potential therapeutics.

In a further approach, we try to understand basic concepts of angiogenesis by manipulating cellular behaviour via nanoagents. like, e.g. structured surfaces, hygrogels, nanoparticles or artificial membranes.

Group members

Florian Gegenfurtner

Lisa Pfitzer

Shuaijun Wang

Christina Moser

Anja Arner

Hilary Ganz

Daniel Rüdiger

Dr. Themistiklis Zisis

 


Alumni

Dr. Kerstin Kick

Dr. Simon Schuster

Dr. Julia Herzog

Dr. Magdalena Menhofer

Dr. Sebastian Rath

Dr. Sabine Weitensteiner

Dr. Johanna Liebl

Dr. Anja Koltermann

Dr. Andrea Rothmeier

Current funding

DFG ZA 186/7-1: 'The role of CDK5 as target in hepatocellular carcinoma (HCC)'.

SFB 1032: 'Controlling cellular functions by structured surfaces. (Artificial angiogenesis)'.


Responsibilities

Head of the Imaging Facility of the Department of Pharmacy

Publications

An up-to-date list of Prof. Dr. Zahler's publications can be found on PubMed.